The surgery can be easier to deal with the future recurrence of breast cancer in high-risk groups, postoperative adjuvant therapy should be taken to reduce the recurrence of what manner? Is taken to contain the epidemic now anthracycline and taxane dose-intensive chemotherapy, or should be used first to anthracycline-based chemotherapy to continue the high-dose chemotherapy combined with autologous stem cell transplant?
Recently, the problem in the United States S9623 research reply.
The results showed that, no matter in what manner, and its disease-free survival and overall survival time were fairly consistent, but the toxicity of high-dose chemotherapy is more special attention.
No comments:
Post a Comment